University of California su vaccino contro il cancro

dal sito dell’University of California di riepilogo delle pubblicazioni, interviste televisive e radiofoniche, e simili:

http://pub.ucsf.edu/fyi/daily/2007/05/11.php

FRIDAY, MAY 11, 2007

…….

UCSF RADIO AND TELEVISION COVERAGE

• Controversial HPV Vaccine (NPR - All Things Considered)
  In an editorial published Thursday in the New England Journal of Medicine, Drs. George Sawaya and Karen Smith-McCune of the University of California, San Francisco, manitain the human papillomavirus (HPV) vaccine produces more questions than answers. After the FDA approval of the vaccine, the federal Centers for Disease Control and Prevention recommended that all 11- and 12-year-old girls in the United States be vaccinated. Smith-McCune said a mandatory vaccine is premature.
• Gonzales: Round Two… (CNN National - The Situation Room with Wolf Blitzer)
  CNN’s Carol Costello gives a brief update on health news of the week, reporting that two UCSF physicians advise cautious use and more studies on the recently FDA approved cervical cancer vaccine Gardasil.
• HPV Vaccine (KGO-TV CH 7 (ABC) San Francisco)
  Two doctors at the University of CA San Francisco are warning against the use of Gardasil, a vaccine against the HPV virus that causes cervical cancer, until further testing is done.
  [This program also aired during the evening drive time]
• Scientists Want More Studies on FDA Approved HPV Vaccine (MSNBC - National)
  A new report in the New England Journal of Medicine discusses the effectiveness of the controversial HPV vaccine Gardasil. Two doctors from the University of California, San Francisco called the benefits of the vaccine modest.
• UCSF Wants More Studies on HPV Vaccine (KRON-TV CH 4 (My Network TV) San Francisco)
  UCSF experts wrote an editorial in the New England Journal of Medicine calling for more studies on a cervical cancer vaccine called Gardasil which is designed to prevent the human papillomavirus (HPV). Dr. George Sawaya at UCSF, says he hopes the editorial will raise questions about the vaccine, specifically whether it works on women who are already sexually active. Dr. Karen Smith McCune, UCSF, tells KRON regular pap smear screenings are needed.

http://www.medicalnewstoday.com/medicalnews.php?newsid=70581

W. Martin Kast — an immunologist of the University of Southern California’s Keck School of Medicine, who was not involved in the research — said, “In a three-year follow-up, it is very hard to reach statistical significance in a disease process that takes about a decade to fully develop.” He added, “Thus, it is not fair to state that the vaccine is not effective. It will be, but it needs more time to materialize.”

L’editoriale pubblicato sul The New England Journal of Medicine

HPV Vaccination — More Answers, More Questions

George F. Sawaya, M.D., and Karen Smith-McCune, M.D., Ph.D. http://content.nejm.org/cgi/content/full/356/19/1991